Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases

Detalhes bibliográficos
Autor(a) principal: Monteiro, D. R.
Data de Publicação: 2015
Outros Autores: Takamiya, A. S., Feresin, L. P., Gorup, L. F., Camargo, E. R., Delbem, A. C. B., Henriques, Mariana, Barbosa, D. B.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/33289
Resumo: Purpose: Silver nanoparticles (SN) have been studied as antibiofilm agents, to prevent Candida-associated denture stomatitis. Consequently, the aim of this study was to investigate the influence of the intermediate and maturation stages of Candida albicans and Candida glabrata biofilms development in the susceptibility to SN. Methods: SN (5 nm) suspensions were synthesized via reduction of silver nitrate by a solution of sodium citrate. These suspensions were used to treat, during 5 h, Candida biofilms grown on acrylic surfaces for 24- (intermediate stage) and 48-h (maturation stage), and their efficacy was determined by total biomass (using crystal violet staining) and colony forming units (CFU) quantification. Results: SN promoted significant reductions (p < 0.05) in the total biomass and in the number of CFUs of Candida biofilms ranging from 23-51.5% and 0.96-1.44-log10, respectively. Moreover, there were no significant differences in the total biofilm biomass (p > 0.05), when the different stages of biofilm development (24 or 48 h) were exposed to SN. Comparing the number of CFUs between 24- and 48-h biofilms treated with SN, a significant difference (p < 0.05) was found only for the strain C. albicans 324LA/94. Conclusions: It was concluded that, in general, the intermediate and maturation stages of biofilm development do not interfere in the susceptibility of C. albicans and C. glabrata biofilms to SN regarding. These findings are essential for the deployment of new therapies aimed at preventing denture stomatitis.
id RCAP_f1bb8092dbd020e844a06899611ce864
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/33289
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phasesSilver nanoparticlesDenture stomatitisBiofilmsCandida albicansCandida glabrataScience & TechnologyPurpose: Silver nanoparticles (SN) have been studied as antibiofilm agents, to prevent Candida-associated denture stomatitis. Consequently, the aim of this study was to investigate the influence of the intermediate and maturation stages of Candida albicans and Candida glabrata biofilms development in the susceptibility to SN. Methods: SN (5 nm) suspensions were synthesized via reduction of silver nitrate by a solution of sodium citrate. These suspensions were used to treat, during 5 h, Candida biofilms grown on acrylic surfaces for 24- (intermediate stage) and 48-h (maturation stage), and their efficacy was determined by total biomass (using crystal violet staining) and colony forming units (CFU) quantification. Results: SN promoted significant reductions (p < 0.05) in the total biomass and in the number of CFUs of Candida biofilms ranging from 23-51.5% and 0.96-1.44-log10, respectively. Moreover, there were no significant differences in the total biofilm biomass (p > 0.05), when the different stages of biofilm development (24 or 48 h) were exposed to SN. Comparing the number of CFUs between 24- and 48-h biofilms treated with SN, a significant difference (p < 0.05) was found only for the strain C. albicans 324LA/94. Conclusions: It was concluded that, in general, the intermediate and maturation stages of biofilm development do not interfere in the susceptibility of C. albicans and C. glabrata biofilms to SN regarding. These findings are essential for the deployment of new therapies aimed at preventing denture stomatitis.This study was supported by the Sao Paulo Research Foundation (FAPESP), Brazil, process 2009/15146-5. The authors are indebted to LIEC-CMDMC and INCTMN/FAPESP-CNPq in the name of Andressa Kubo for preparing and characterizing the colloidal suspensions of silver nanoparticles. We also thank Dr. David Williams (Cardiff University, Cardiff, UK) for providing the strain 324LA/94, and George Duchow for the English review.ElsevierUniversidade do MinhoMonteiro, D. R.Takamiya, A. S.Feresin, L. P.Gorup, L. F.Camargo, E. R.Delbem, A. C. B.Henriques, MarianaBarbosa, D. B.20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/33289eng1883-19581883-195810.1016/j.jpor.2014.07.00425168655http://www.journals.elsevier.com/journal-of-prosthodontic-research/info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:30:47Zoai:repositorium.sdum.uminho.pt:1822/33289Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:26:02.228566Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
title Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
spellingShingle Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
Monteiro, D. R.
Silver nanoparticles
Denture stomatitis
Biofilms
Candida albicans
Candida glabrata
Science & Technology
title_short Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
title_full Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
title_fullStr Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
title_full_unstemmed Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
title_sort Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases
author Monteiro, D. R.
author_facet Monteiro, D. R.
Takamiya, A. S.
Feresin, L. P.
Gorup, L. F.
Camargo, E. R.
Delbem, A. C. B.
Henriques, Mariana
Barbosa, D. B.
author_role author
author2 Takamiya, A. S.
Feresin, L. P.
Gorup, L. F.
Camargo, E. R.
Delbem, A. C. B.
Henriques, Mariana
Barbosa, D. B.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Monteiro, D. R.
Takamiya, A. S.
Feresin, L. P.
Gorup, L. F.
Camargo, E. R.
Delbem, A. C. B.
Henriques, Mariana
Barbosa, D. B.
dc.subject.por.fl_str_mv Silver nanoparticles
Denture stomatitis
Biofilms
Candida albicans
Candida glabrata
Science & Technology
topic Silver nanoparticles
Denture stomatitis
Biofilms
Candida albicans
Candida glabrata
Science & Technology
description Purpose: Silver nanoparticles (SN) have been studied as antibiofilm agents, to prevent Candida-associated denture stomatitis. Consequently, the aim of this study was to investigate the influence of the intermediate and maturation stages of Candida albicans and Candida glabrata biofilms development in the susceptibility to SN. Methods: SN (5 nm) suspensions were synthesized via reduction of silver nitrate by a solution of sodium citrate. These suspensions were used to treat, during 5 h, Candida biofilms grown on acrylic surfaces for 24- (intermediate stage) and 48-h (maturation stage), and their efficacy was determined by total biomass (using crystal violet staining) and colony forming units (CFU) quantification. Results: SN promoted significant reductions (p < 0.05) in the total biomass and in the number of CFUs of Candida biofilms ranging from 23-51.5% and 0.96-1.44-log10, respectively. Moreover, there were no significant differences in the total biofilm biomass (p > 0.05), when the different stages of biofilm development (24 or 48 h) were exposed to SN. Comparing the number of CFUs between 24- and 48-h biofilms treated with SN, a significant difference (p < 0.05) was found only for the strain C. albicans 324LA/94. Conclusions: It was concluded that, in general, the intermediate and maturation stages of biofilm development do not interfere in the susceptibility of C. albicans and C. glabrata biofilms to SN regarding. These findings are essential for the deployment of new therapies aimed at preventing denture stomatitis.
publishDate 2015
dc.date.none.fl_str_mv 2015
2015-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/33289
url http://hdl.handle.net/1822/33289
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1883-1958
1883-1958
10.1016/j.jpor.2014.07.004
25168655
http://www.journals.elsevier.com/journal-of-prosthodontic-research/
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132746499489792